Compare Expand Energy Corporation Common Stock (EXE) vs Exelixis Inc. Common Stock (EXEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expand Energy Corporation Common Stock vs Exelixis Inc. Common Stock — how do they compare? Expand Energy Corporation Common Stock trades at $90.94 (market cap $21.38B), while Exelixis Inc. Common Stock trades at $60.95 (market cap $14.75B). The key difference: Expand Energy Corporation Common Stock is the larger of the two by market cap, and Expand Energy Corporation Common Stock pays a 2.49% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expand Energy Corporation Common Stock for 0 Days and Exelixis Inc. Common Stock for 3 Days on average.
| EXE | EXEL | |
|---|---|---|
Market Cap | $21.38B | $14.75B |
Volume | 3,544,570 | 2,624,658 |
Sector | Energy | Health |
52-Week High | $122.89 | $60.99 |
52-Week Low | $84.09 | $34.54 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $24.45B | $14.07B |
Dividend Yield | 2.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EXEL trades at $59.51, down 0.52% on the day but near its 52-week high of $61.66 reached on October 12, 2026. The stock shows strong technical momentum with bullish moving averages and has consistently beaten earnings estimates in recent quarters. Recent news highlights include a three-month FDA review delay for zanzalintinib but continued growth in CABOMETYX revenue, which surpassed $3 billion annually.
The outlook remains positive with strong profitability metrics (35.33% net margin, 44.39% ROE) and projected revenue growth to $2.4 billion in 2026. Key risks include regulatory delays for new drug approvals and competitive pressures in oncology. Analyst consensus is mixed with 48% buy ratings but a price target of $52.33 suggesting potential downside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expand Energy Corporation Common Stock
Expand Energy Corporation is a US natural gas producer formed from the 2024 merger of Chesapeake Energy and Southwestern Energy, developing gas assets concentrated in the Appalachia and Haynesville basins.
Read more on EXE →About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →
